Back to top

Image: Bigstock

Gol Linhas' (GOL) May Traffic Increases From April Levels

Read MoreHide Full Article

Gol Linhas Aereas Inteligentes posted impressive traffic numbers for the month of May, as air-travel demand picks up on increased vaccination programs.

Traffic, measured in revenue passenger kilometers, inched up 65% sequentially in May. With increased travel demand, the company increased its capacity significantly. In the same time frame, capacity measured in available seat kilometers rallied 55.1%. Since traffic surge was more than capacity expansion, load factor (% of seats filled by passengers) moved up 5.2 percentage points (pp) from April levels to 88%.  

Notably, traffic surged 519% year over year in May. In the same time frame, capacity expanded 425%. Since traffic surge was more than capacity expansion, load factor increased 13.3 pp to 88% from year-ago period’s levels. Gol Linhas’ total monthly departures skyrocketed 401% and seats surged 457.3%.

Gol Linhas transported 1.1 million passengers May (up 547% a year-over-year basis). The Latin America-based airline did not operate international flights during May.

Zacks Rank & Stocks to Consider

Gol Linhas currently carries a Zacks Rank #4 (Sell).

Some better-ranked stocks in the Zacks Transportation sector include Landstar System, Inc. (LSTR - Free Report) , Triton International Limited and Herc Holdings Inc. (HRI - Free Report) . Herc Holdings and Landstar sport a Zacks Rank #1 (Strong Buy), while Triton carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term (three to five years) expected earnings per share growth rate for Landstar, Triton and Herc Holdings is projected at 12%, 10% and 42.9%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

 


Unique Zacks Analysis of Your Chosen Ticker


Pick one free report - opportunity may be withdrawn at any time


Landstar System, Inc. (LSTR) - $25 value - yours FREE >>

Herc Holdings Inc. (HRI) - $25 value - yours FREE >>

Published in